Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)
Aging | Diseases of the Cardiovascular System | Diseases of the Nervous System
What is the purpose of this trial?
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
- Ages75 years and older
- Trial withDuke University
- Start Date05/19/2021
- End Date06/30/2026
- Last Updated11/16/2021
- Study HIC#2000029974